Contract HHSD2002012M53210P
Public Health England · Department Of Health And Human Services · August 29, 2012
Public Health England was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on August 29, 2012 for $6,000 of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 7, 2016.
Contract details
- PIID
- HHSD2002012M53210P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Chemicals
- First action
- August 29, 2012
- Latest action
- November 7, 2016
Description
ACQUISITION OF RECOMBINANT RSTFR 1ST WHO REFERENCE REAGENT
Modification timeline
-
November 7, 2016Mod 2$0
-
July 19, 2013Mod 1$2.0K
-
August 29, 2012Base award$3.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002012M53210P?
Contract HHSD2002012M53210P is a federal contract awarded to Public Health England by Department Of Health And Human Services on August 29, 2012 for $6,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 2 times since the base award.
Who won contract HHSD2002012M53210P?
Public Health England won contract HHSD2002012M53210P from Department Of Health And Human Services.
How much is contract HHSD2002012M53210P worth?
Contract HHSD2002012M53210P has obligated $6,000 to date.